| Sign In to gain access to subscriptions and/or personal tools. |
Near-optimal Conditions for the In Vitro Culture of Hemopoietic Progenitor Cells in Bone Marrow from the Rat
1 Division of Cellular and Molecular Medicine, Section for Cellular and Molecular Pathology, St George’s, University of London, United Kingdom Correspondence: Dr. G. Molyneux, Breakthrough Breast Cancer Centre, Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK; e-mail:gemma.molyneux{at}icr.ac.uk.
In vitro techniques for the culture of hemopoietic stem cells and committed hemopoietic progenitor cells in rat bone marrow have not been adequately described in the literature. In the present investigations, and using commercially available hemopoietic cytokines and growth factors, the conditions required to perform long-term bone marrow culture (LTBMC) using rat femoral bone marrow were studied, in conjunction with the colony-forming unit cell assay (CFU-C), to quantify the number of progenitor cells. CFU-C production by LTBMCs, set up using Iscove’s modified Dulbecco’s medium supplemented with fetal calf serum and horse serum, ceased after week 2 of culture. However, the duration of CFU-C production was significantly increased by supplementing LTBMCs with the cytokine recombinant mouse stem cell factor or recombinant rat stem cell factor.
Key Words: long-term bone marrow culture • rat • hemopoietic progenitor cells • colony-forming unit cell assay • mouse stem cell factor • in vitro culture Abbreviations: BFU-E, burst-forming unit erythroid • BM, bone marrow • CFU-C, colony-forming unit cell • CFU-GEM, colony-forming units granulocyte–macrophage and erythroid elements • CFU-GM, colony-forming units granulocyte–macrophage • FCS, fetal calf serum • HS, horse serum • IMDM, Iscove’s modified Dulbecco’s medium • LTBMC, long-term bone marrow culture • rhEpo, recombinant human erythropoietin • rhG-CSF, recombinant human granulocyte colony–stimulating factor • rhIL-6, recombinant human interleukin 6 • rmIL-3, recombinant mouse interleukin 3 • rmSCF, recombinant mouse stem cell factor • rrSCF, recombinant rat stem cell factor • SCF, stem cell factor
The hemopoietic system of laboratory animals and man is particularly sensitive to the toxic effects of many drugs (e.g., chloramphenicol, chloroquine, penicillamine, busulphan, gold salts) and chemicals (e.g., benzene, lindane, arsenic, alcohol). Exposure to such agents may have severe hematological consequences (Catovsky and Hoffbrand 1999; Heimpel 2000; Jandl 1996; Young and Alter 1994; Young and Vincent 1980). In vitro bone marrow culture assays are useful in assessing toxicity and injury to hemopoietic stem cells and progenitor cell populations in both experimental animals and man (Gasper 2000; Schofield 1986; Williams 2000). Culture techniques for the quantification of stem and progenitor cells using human bone marrow, as well as mouse, cat, dog, horse, and sheep bone marrow, are well defined and recorded (Bagby and Heinrich 2000; Gengozian 2000; Kohn et al. 1995; Swardson and Kociba 1994; Swardson and Kociba 1996). However, in vitro culture techniques have not been adequately described for bone marrow samples from the rat, and indeed, a recent literature search has produced no relevant publications in this field. Considering the importance of the rat in preclinical drug safety evaluation studies in the pharmaceutical industry, and the widespread use of this species in experimental toxicology investigations and in other areas of biomedical research (Mutai 2000), it would be extremely useful if in vitro culture techniques for bone marrow from the rat were routinely available. Nevertheless, some short-term culture assays have been described using rat bone marrow to identify stem cells and committed progenitor cells (Khaldoyanidi et al. 1997; Lucas et al. 1999). However, these assays have tended to be performed using feeder cells under agar as a source of hemopoietic cytokines and growth factors (Khaldoyanidi et al. 1997); alternatively, spleen-or lung-conditioned media in semisolid methylcellulose have been used (Kim et al. 2001; Kimura et al. 1986). Using the long-term bone marrow culture (LTBMC) system described by Dexter and others (Brühl et al. 1988; Dexter and Lajtha 1974; Dexter et al. 1977; Gartner and Kaplan 1980) as a starting point, in recent studies with myelotoxic drugs (Gibson et al. 2003; Molyneux et al. 2005; Turton, Fagg et al. 2006), near-optimal conditions for the long-term culture of rat femoral bone marrow have now been identified. In addition, a short-term culture method has also been developed to quantify the number of committed hemopoietic progenitor cells in rat bone marrow using defined, commercially available, hemopoietic cytokines and growth factors. This last (short-term) culture technique was recently used to assess changes in the numbers of progenitor cells, from both myeloid and erythroid lineages, in the rat following the administration of the myelotoxic agent chlorambucil (Molyneux et al. 2004). It is considered that the identification of optimal culture conditions for the LTBMC of rat bone marrow cells, using defined media, would allow further investigations to be carried out on the myelotoxic effects of anticancer agents and other drugs and chemicals on early rat hemopoietic progenitor cells and on rat bone marrow stromal cells. Therefore, using these methods, it would be possible to quantify the number of hemopoietic stem and progenitor cells in animals treated with experimental agents. In addition, it would provide a technique to assess bone marrow stroma formation and allow the evaluation of the potential toxic effects of drugs and chemicals on rat bone marrow cells, and on the bone marrow microenvironment. Furthermore, the development of in vitro clonogenic assays for rat bone marrow cells would allow investigations to be conducted on the hemotoxicity of agents in vitro. Femoral bone marrow samples from the outbred Hanover Wistar rat and the inbred F344 rat were investigated in the present studies. Both of these stocks/strains are widely used in toxicologic investigations (Festing 1979, 1990).
Bone Marrow Collection Twelve adult (eight- to ten-week-old) female outbred Hanover Wistar rats and twelve inbred F344 rats (B & K Universal Ltd., Hull, UK) were sacrificed by the intraperitoneal injection of pentobarbitone sodium (Sagatal, Rhône Mérieux Ltd., Harlow, UK). The bone marrow (BM) contents of the left and right femora were each aspirated into 5 mL Iscove’s modified Dulbecco’s medium (IMDM; Life Technologies, Paisley, UK) supplemented with 10% fetal calf serum (FCS; PAA Laboratories GmbH, Linz, Austria).
Long-term Bone Marrow Culture
Colony-forming Unit Cell Assay
Statistical Analysis Nonadherent cells harvested from LTBMC grown without SCF, or with the addition of either rmSCF or rrSCF, were compared at each time point using a one-way ANOVA followed by Tukey’s highest significance test for post hoc pairwise multiple comparison. All statistical analysis was carried out using GraphPad Prism Version 4.00 for Windows (GraphPad Software, San Diego, CA, USA).
The number of committed progenitor cells produced by 105 fresh rat bone marrow cells was assessed using the colony-forming unit cell (CFU-C) assay. Cultures were supplemented with rhEpo, rmIL-3,rhIL-6,rhG-CSF, and either rmSCF or rrSCF (Table 1). The production of CFU-GM colonies in cultures from Hanover Wistar rat bone marrow was comparable when cultures were supplemented with either rmSCF (40.8 colonies) or rrSCF (38.7 colonies). The number of erythroid colonies produced was, however, significantly higher in cultures supplemented with rrSCF (10.8 colonies, rrSCF; 4.3 colonies, rmSCF; p < .001). The number of CFU-GM colonies produced by F344 bone marrow was higher in cultures supplemented with rmSCF (38.0 colonies, rmSCF; 24.0 colonies, rrSCF; p < .001); however, the number of erythroid colonies was larger in cultures supplemented with rrSCF (48.4 colonies, rrSCF; 19.3 colonies, rmSCF; p < .001).
The addition of rmSCF profoundly improved Hanover Wistar rat LTBMCs, compared with cultures without SCF (Table 2); the number of CFU-GM colonies was significantly increased at all time points from week 1 to week 5 of culture (p < .01 or p < .001). The production of erythroid colonies was also sustained for a longer period of time (until week 5) in cultures supplemented with rmSCF in comparison with cultures without SCF (Table 2). However, this increase in the number of erythroid colonies in cultures with rmSCF was statistically significant only at weeks 1 and 2 of culture (p < .001 at both time points).
The addition of rrSCF had a similar overall effect on Hanover Wistar LTBMCs, as did supplementation with rmSCF (Table 2). It is seen that production of CFU-GM colonies was sustained until week 5 of culture, and the number of colonies generated was significantly increased at weeks 1, 2, and 3 in comparison with cultures without SCF (p < .01 or p < .001). Erythroid colony production was also improved by the addition of rrSCF compared with cultures lacking SCF (Table 2). Cultures set up with rmSCF and with rrSCF were generally comparable in the number of colonies produced (Table 2). However, LTBMCs supplemented with rmSCF gave rise to significantly more CFU-GM colonies at week 4 of culture, and to significantly more erythroid colonies at week 2 of culture (p < .05 for both CFU-GM and erythroid colonies). Using F344 rat bone marrow, LTBMCs also performed significantly better with the addition of either rmSCF or rrSCF compared to cultures without SCF (Table 3). Compared with LTBMCs without SCF, cultures supplemented with rmSCF produced significantly more CFU-GM colonies at week 1, 2, 3, and 4 and significantly more erythroid colonies at week 1 and 2. The addition of rrSCF did not improve colony output in F344 LTBMCs to the same extent as that seen with rmSCF (Table 3). However, both CFU-GM and erythroid colonies were significantly increased in cultures supplemented with rrSCF at weeks 1 and 2 of culture in comparison with cultures without SCF. In terms of the numbers of CFU-GM colonies and erythroid colonies produced in F344 rat LTBMCs supplemented with rmSCF or rrSCF, statistical analysis showed no significant differences in the number of colonies generated by either of the two SCFs.
The present studies, designed to identify the optimal conditions for LTBMC of rat femoral bone marrow cells, demonstrate that the number of committed progenitor cells can be quantified when the marrow is cultured in semisolid methylcellulose supplemented with defined, commercially available cytokines and growth factors. In general, the long-term culture of bone marrow from the outbred Hanover Wistar rat and the inbred F344 rat gave similar results (Tables 2 and 3 ). However, the addition of rmSCF or rrSCF appeared to be essential; rmSCF and rrSCF both improved the duration of the LTBMCs and increased the number of colonies produced weekly in the CFU-C assay. These results find a parallel in the study of Dunlop et al. (1993), who reported that rrSCF enhanced the proliferation of lineage-negative mouse hemopoietic progenitor cells. Similar findings have been reported in studies with SCF in canine bone marrow cultures (Sandmeier et al. 1996; Shull et al. 1992). The culture of rat bone marrow using long-term and short-term culture assays would allow the measurement of changes in both committed progenitor cells and in more primitive bone marrow progenitor cells. This would therefore provide techniques to measure the toxic effects of experimental agents on the bone marrow compartment of rats, which has not been possible previously. It is considered that the present studies on rat bone marrow culture complement the well-defined and widely used techniques already available for the in vitro culture of marrow from other species, such as man, mouse, cat, dog, and horse (Gengozian 1998; Gengozian and Legendre 1995; Kohn et al. 1995; Swardson and Kociba 1994; Swardson and Kociba 1996; Whitwam et al. 1998). Furthermore, the present experiments would allow a second rodent species to be considered in comparative studies with bone marrow cultures, whereas in the past only mouse bone marrow could be used. The present techniques will also be useful in a number of areas of hematological research, and in particular in investigations on the assessment of drug- and chemical-induced bone marrow toxicity, and in the wider fields of investigative toxicology and experimental pathology. In conclusion, although it is appreciated that the present investigations have resulted in the development of a technique that allows the setting up of rat LTBMCs, with the production of CFU-Cs, the time period involved is only up to a maximum of four to five weeks (Tables 2 and 3 ). Therefore, it is reasonable to point out that the technique requires further development to extend this present four- to five-week period of culture. Also, although the longevity of the present rat LTBMCs compares with the period of culture for mouse LTBMCs (Dunlop et al. 1993), the current technique in the rat does leave room for further improvement. Nevertheless, the present approach permits worthwhile hematological investigations with rat bone marrow to be carried out, and it is hoped that other research workers in the field will consider the present methods as a starting point and that they will carry out experiments to further improve the technique.
We would like to acknowledge with thanks the advice given by Dr. W. Sones on the statistical analysis of the data. We also thank Amgen UK Ltd., Janssen-Cilag Ltd., and Novartis Pharmaceuticals Ltd. for their kind donation of cytokines.
Bagby, GC, & Heinrich, MC. In Hoffman, R, Benz, EJ, & Shattil, SJ (Eds.). (2000). Growth factors, cytokines, and the control of hematopoiesis. Hematology; Basic Principles and Practice. (3rd ed) 154-202). New York: Churchill Livingstone Brühl, P, Mergenthaler, HG, & Dörmer, P. (1988). Haemopoietic inductive capacity of irradiated stromal cell layers in human micro long-term bone marrow cultures. Cell Tissue Kinet, 21, 411-17[Web of Science][Medline] [Order article via Infotrieve] Catovsky, D, & Hoffbrand, AV. In Hoffbrand, AV, Lewis, SM, & Tuddenham, EGD (Eds.). (1999). Acute Leukaemia. Postgraduate Haematology. (4th ed) 373-404). Oxford: Butterworth Dexter, TM, & Lajtha, LG. (1974). Proliferation of haemopoietic stem cells in vitro. Br J Haematol, 28, 525-530[Web of Science][Medline] [Order article via Infotrieve] Dexter, TM, Wright, EG, Krizsa, F, & Lajtha, LG. (1977). Regulation of haemopoietic stem cell proliferation in long term bone marrow cultures. Biomedicine, 27, 344-49[Web of Science][Medline] [Order article via Infotrieve] Dunlop, JM, Firkin, F, McNiece, IK, & Bertoncello, I. (1993). Accelerated establishment of murine long-term bone marrow cultures by addition of stem cell factor. Exp Hematol, 21, 769-73[Web of Science][Medline] [Order article via Infotrieve] Festing, MFW. (1979). Inbred Strains in Biomedical Research. London: Macmillan Festing, MFW. (1990). Contemporary issues in toxicology: Use of genetically heterogeneous rats and mice in toxicological research: A personal perspective. Toxicol Appl Pharmacol, 102, 197-204[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Gartner, S, & Kaplan, HS. (1980). Long-term culture of human bone marrow cells. Proc Natl Acad Sci U S A, 77, 4756-59 Gasper, PW. In Feldman, B, Zinkl, JG, & Jain, NC (Eds.). (2000). Stem Cell Biology. Schalm’s Veterinary Hematology. (5th ed) 69-73). Philadelphia: Lippincott Gengozian, N. (1998). Development of monoclonal antibodies to erythroid progenitors in feline bone marrow. J Vet Immunol Immunopathol, 64, 229-312 Gengozian, N. In Feldman, B, Zinkl, JG, & Jain, NC (Eds.). (2000). Identification and isolation of hemopoietic progenitors. Schlam’s Veterinary Hematology. (5th ed) 91-96). Philadelphia: Lippincott Gengozian, N, & Legendre, AM. (1995). Separation of feline bone marrow cells by counterflow centrifugal elutriation. Identification and isolation of presumptive early and late myeloid/erythroid progenitors. Transplantation, 60, 836-41[Web of Science][Medline] [Order article via Infotrieve] Gibson, FM, Andrews, CM, Diamanti, P, Rizzo, S, Macharia, G, Gordon-Smith, EC, Williams, T, & Turton, J. (2003). A new model of busulphan-induced chronic bone marrow aplasia in the female BALB/c mouse. Int J Exp Pathol, 84, 31-47[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Heimpel, H. In Schrezenmeier, H, & Bacigalupo, A (Eds.). (2000). Epidemiology and aetiology of aplastic anaemia. Aplastic Anaemia; Pathophysiology and Treatment (pp.97-116). Cambridge, UK: Cambridge University Press Jandl, JH. (1996). Blood; a Textbook of Haematology. (2nd ed). Boston: Little Brown Khaldoyanidi, S, Schnabel, D, Fohr, N, & Zoller, M. (1997). Functional activity of CD44 isoforms in haemopoiesis of the rat. Br J Haematol, 96, 31-45[Web of Science][Medline] [Order article via Infotrieve] Kim, S, Stair, EL, Lochmiller, RL, Lish, JW, & Qualls, CW. (2001). Evaluation of myelotoxicity in cotton rats (Sigmodon hispidus) exposed to environmental contaminants. I. In vitro bone-marrow progenitor culture. J Toxicol Environ Health A, 62, 83-96[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Kimura, H, Finch, CA, & Adamson, JW. (1986). Hematopoiesis in the rat: quantitation of hematopoietic progenitors and the response to iron deficiency anaemia. J Cell Physiol, 126, 298-306[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Kohn, CW, Swardson, CJ, Provost, P, Gilbert, RJ, & Couto, GC. (1995). Myeloid and megakaryocytic hypoplasia in related standard-breds. J Vet Int Med, 9, 315-23 Lucas, T, Kruglnger, W, & Samorapoompichit, P. (1999). Self-renewal, maturation and differentiation of the rat myelomonocyte hemopoietic stem cell. FASEB J, 13, 263-72 Molyneux, G, Rizzo, S, Gibson, FM, Sulsh, S, Andrews, CM, Pilling, AM, Nakshbandi, T, Gordon-Smith, EC, & Turton, JA. (2004). Haemotoxicity of chlorambucil in the Wistar Hanover rat with particular reference to bone marrow culture, marrow cell apoptosis and levels of FLT3 ligand. Comp Clin Path, 13, 70-81[CrossRef] Molyneux, G, Gibson, FM, Gordon-Smith, EC, Pilling, AM, Liu, KC, Rizzo, S, Sulsh, S, & Turton, JA. (2005). The haemotoxicity of mitomycin in a repeat dose study in the female CD-1 mouse. Int J Exp Path, 86, 415-30[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Mutai, M. In Krinke, GJ (Ed.). (2000). National and international guidelines for the conduct of chemical safety studies: choice of strains. The Laboratory Rat (pp.17-27). San Diego, CA: Academic Press Sandmeier, BM, Storb, R, Santos, EB, Krizanac-Bengez, L, Lian, T, McSweeney, PA, Yu, C, Schuening, FG, Deeg, HJ, & Graham, T. (1996). Allogenic transplant of canine peripheral blood stem cells mobilised by recombinant canine hemopoietic growth factors. Blood, 87, 3508-13 Schofield, R. (1986). Assessment of cytotoxic injury to bone marrow. Br J Cancer, 53(Suppl_VII), 115-25[Web of Science][Medline] [Order article via Infotrieve] Shull, RM, Suggs, SV, Langley, KE, Okino, KH, Jacobsen, FW, & Martin, FH. (1992). Canine stem cell factor (c-kit ligand) supports the survival of hematopoietic progenitors in long-term canine marrow culture. Exp Hematol, 20, 1118-24[Web of Science][Medline] [Order article via Infotrieve] Swardson, CJ, & Kociba, GJ. (1994). Suppression of erythroid progenitors in ponies infected with equine infectious anaemia virus. Comp Haematol Int, 4, 108-13[CrossRef] Swardson, CJ, & Kociba, GJ. (1996). Clonogenic haematopoietic progenitor assays from clinically normal horses. Comp Haematol Int, 6, 187-93[CrossRef] Turton, JA, Fagg, R, Sones, WR, Williams, TC, & Andrews, CM. (2006). Characterization of the myelotoxicity of chloramphenicol succinate in the B6C3F1 mouse. Int J Exp Pathol, 87, 101-12[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Turton, JA, Sones, WR, Andrews, CM, Pilling, AM, Williams, TC, Molyneux, G, Rizzo, S, Gordon-Smith, EC, & Gibson, FM. (2006). Further development of a model of chronic bone marrow aplasia in the busulphan-treated mouse. Int J Exp Pathol, 87, 49-63[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Whitwam, T, Haskins, ME, Henthorn, PS, Kraszewski, JN, Kleiman, SE, Seidel, NE, Bodine, DM, & Puck, JM. (1998). Retroviral marking of canine bone marrow: long-term, high-level expression of human interleukin-2 receptor common gamma chain in canine lymphocytes. Blood, 92, 1565-75 Williams, DA. In Hoffman, R, Benz, EJ, & Shattil, SJ (Eds.). (2000). Stem cell model of hematopoiesis. Hematology; Basic Principles and Practice. (3rd ed) 126-38). New York: Churchill Livingstone Young, GAR, & Vincent, PC. In Gordon-Smith, EC (Ed.). (1980). Drug-induced agranulocytosis. Clinics in Haematology; Haematological Effects of Drug Therapy, 9, 483-504). London: Saunders Young, NS, & Alter, BP. (1994). Aplastic Anaemia; Acquired and Inherited. Philadelphia: Saunders
Toxicologic Pathology, Vol. 37, No. 2,
170-174 (2009)
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
|
|
 |
|
Sign In to gain access to subscriptions and/or personal tools.
Top
Abstract
Introduction